Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N R Cutler

Showing results (81-90 of 166) with videos related to

Pageof 17
Sort By:
The Annals of Pharmacotherapy|January 1, 1994
Fleroxacin treatment of stage IV pressure ulcers with associated osteomyelitisN R Cutler, R D Seifert, J J Sramek, et al.
Alzheimer Disease and Associated Disorders|January 7, 1999
Efficacy of xanomeline in Alzheimer disease: cognitive improvement measured using the Computerized Neuropsychological Test Battery (CNTB)A E Veroff, N C Bodick, W W Offen, et al.
The Annals of Pharmacotherapy|October 1, 1994
Safety and tolerance of intravenous nimodipineJ J Sramek, A H Heller, P R Sundaresan, et al.
Lancet (London, England)|April 26, 1980
Plasma opioid activity in manic-depressive illnessD Pickar, N R Cutler, D Naber, et al.
Journal of Clinical Pharmacology|June 1, 1990
Clinical safety, tolerance, and plasma levels of the oral anticholinesterase 1,2,3,4-tetrahydro-9-aminoacridin-1-oL-maleate (HP 029) in Alzheimer's disease: preliminary findingsN R Cutler, M F Murphy, R J Nash, et al.
British Journal of Clinical Pharmacology|November 1, 1994
Pharmacokinetics of co-administered didanosine and stavudine in HIV-seropositive male patientsR D Seifert, M B Stewart, J J Sramek, et al.
Life Sciences|January 1, 1996
Safety/tolerability trial of SDZ ENA 713 in patients with probable Alzheimer's diseaseJ J Sramek, R Anand, T S Wardle, et al.
Life Sciences|January 1, 1995
Safety and tolerability of CI-979 in patients with Alzheimer's diseaseJ J Sramek, A J Sedman, P A Reece, et al.
Journal of Human Hypertension|November 1, 1995
Anti-hypertensive effects of intravenous compared with oral captoprilJ J Sramek, J J Brennan, D R Much, et al.
Biological Psychiatry|April 1, 1984
Effects of chronic desipramine on plasma norepinephrine concentrations and cardiovascular parameters in elderly depressed women: a preliminary reportN R Cutler, A P Zavadil, M Linnoila, et al.
Pageof 17

Showing results (81-90 of 166) with videos related to

Sort By:
Pageof 17
The Annals of Pharmacotherapy|January 1, 1994
Fleroxacin treatment of stage IV pressure ulcers with associated osteomyelitisN R Cutler, R D Seifert, J J Sramek, et al.
Alzheimer Disease and Associated Disorders|January 7, 1999
Efficacy of xanomeline in Alzheimer disease: cognitive improvement measured using the Computerized Neuropsychological Test Battery (CNTB)A E Veroff, N C Bodick, W W Offen, et al.
The Annals of Pharmacotherapy|October 1, 1994
Safety and tolerance of intravenous nimodipineJ J Sramek, A H Heller, P R Sundaresan, et al.
Lancet (London, England)|April 26, 1980
Plasma opioid activity in manic-depressive illnessD Pickar, N R Cutler, D Naber, et al.
Journal of Clinical Pharmacology|June 1, 1990
Clinical safety, tolerance, and plasma levels of the oral anticholinesterase 1,2,3,4-tetrahydro-9-aminoacridin-1-oL-maleate (HP 029) in Alzheimer's disease: preliminary findingsN R Cutler, M F Murphy, R J Nash, et al.
British Journal of Clinical Pharmacology|November 1, 1994
Pharmacokinetics of co-administered didanosine and stavudine in HIV-seropositive male patientsR D Seifert, M B Stewart, J J Sramek, et al.
Life Sciences|January 1, 1996
Safety/tolerability trial of SDZ ENA 713 in patients with probable Alzheimer's diseaseJ J Sramek, R Anand, T S Wardle, et al.
Life Sciences|January 1, 1995
Safety and tolerability of CI-979 in patients with Alzheimer's diseaseJ J Sramek, A J Sedman, P A Reece, et al.
Journal of Human Hypertension|November 1, 1995
Anti-hypertensive effects of intravenous compared with oral captoprilJ J Sramek, J J Brennan, D R Much, et al.
Biological Psychiatry|April 1, 1984
Effects of chronic desipramine on plasma norepinephrine concentrations and cardiovascular parameters in elderly depressed women: a preliminary reportN R Cutler, A P Zavadil, M Linnoila, et al.
Pageof 17